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Therapeutical hypothermia after cardiopulmonary 
resuscitation: evidences and practical issues
Hipotermia terapêutica pós-reanimação cardiorrespiratória: 
evidências e aspectos práticos 
REVIEW ARTICLE
INTRODUCTION
Therapeutic hypothermia (TH) is a controlled decrease of the patients’ 
central temperature with pre-established therapeutic objectives. This 
treatment has been used for more than 50 years in cardiac surgeries(1) and 
more recently in neurological surgeries.(2) During the last six years this 
subject has gained momentum once again and has become one of the well 
established therapies after a cardiac arrest (CA) in adults. 
During a CA, spontaneous circulation stops and vital organs perfu-
sion is interrupted. Chest compressions, if well performed, provide a 
blood flow of up 30% in relation to the condition. Better perfusion 
of the vital organs will only take place after spontaneous circulation 
returns in patients successfully submitted to cardiorespiratory resuscita-
tion (CRR) maneuvers. Main beneficial mechanisms of hypothermia for 
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ABSTRACT 
Cardiac arrest survivors frequently 
suffer from ischemic brain injury associ-
ated with poor neurological outcome and 
death. Therapeutic hypothermia improves 
outcomes in comatose survivors after re-
suscitation from out-of-hospital cardiac 
arrest. Considering its formal recommen-
dation as a therapy, post-return of sponta-
neous circulation after cardiac arrest, the 
objective of this study was to review the 
clinical aspects of therapeutic hypotherm-
ia. Non-systematic review of articles using 
the keywords “cardiac arrest, cardiopulmo-
nary resuscitation, cooling, hypothermia, 
post resuscitation syndrome” in the Med-
Line database was performed. References 
of these articles were also reviewed. Un-
conscious adult patients with spontaneous 
circulation after out-of-hospital ventricular 
fibrillation or pulseless ventricular tachy-
cardia should be cooled. Moreover, for 
any other rhythm or in the intra-hospital 
scenario, such cooling may also be benefi-
cial. There are different ways of promoting 
hypothermia. The cooling system should 
be adjusted as soon as possible to the tar-
get temperature. Mild therapeutic hypo-
thermia should be administered under 
close control, using neuromuscular block-
ing drugs to avoid shivering. The rewarm-
ing process should be slow, and reach 36º 
C, usually in no less then 8 hours. When 
temperature increases to more than 35º C, 
sedation, analgesia, and paralysis could be 
discontinued. The expected complications 
of hypothermia may be pneumonia, sep-
sis, cardiac arrhythmias, and coagulopathy. 
In spite of potential complications which 
require rigorous control, only six patients 
need to be treated to save one life.
Keywords: Hypothermia induced/ad-
verse effects; Heart arrest/complications; 
Heart arrest/therapy; Cardiopulmonary 
resuscitation/complications; Cardiopul-
monary resuscitation/therapy
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comatose patients recovered from CRR are shown in 
chart 1.
Chart 1 - Beneficial mechanisms of hypothermia in comato-
se patients recovered from a cardiorespiratory arrest (24-26) 
1. Reduction of cerebral oxygen consumption 
2. Suppression of chemical reactions associated to reperfusion 
injuries 
3. Reduction of free radical reactions that increase cerebral 
damage 
4. Reduction of intracellular calcium release 
5. Modulation of apoptosis 
6. Modulation of anti-inflammatory response 
7. Protection of the lipoprotein membranes
MAIN EVIDENCE FOUND IN MEDICAL LIT-
ERATURE
Patients admitted to the hospital after an out-of-
hospital CA, in general, show a significant neurologi-
cal anoxic injury and high mortality.(3) During the last 
11 years various studies in experimental models have 
disclosed that neurological injury after overall severe 
anoxia is reduced when TH is applied.
The first of these studies, published by Bernard 
et al (4) in 1997, induced hypothermia (33º C) in 22 
victims of out-of-hospital CA admitted to the emer-
gency room. External cooling was performed and 
maintained for 12 hours in the intensive care unit 
(ICU). After comparison with historical control, an 
improved survival was noted for patients submitted 
to cooling (mortality of 45% versus 77% in groups 
without TH), with no significant adverse effects re-
lated to TH. Next, various publications disclosed the 
feasibility and safety of TH, in addition to improved 
neurological outcome, and a suggestion of lower mor-
tality in the group treated with TH.(4-13) 
Two large clinical trials were published in the same 
edition of the New England Journal of Medicine, 
2002, on this subject.(5,6) Both showed the beneficial 
effects of hypothermia on neurological outcomes – 
one showed a significant decrease of mortality, leading 
the International Liaison Committee on Resuscitation 
(ILCOR) to publish guidelines in July 2003.(14) They 
recommended use of TH (32º C to 34º C) for uncon-
scious patients after out-of-hospital CA, during 12 to 
24 hours when the initial rhythm of CA was ventricu-
lar fibrillation (VF) and suggested that presumably 
this technique would be also beneficial for other CA 
rhythms and for intra-hospital CA.
An Australian study by Stephen Bernard et al.(5) 
was developed in four emergency departments in Mel-
bourne. Patients of the study were comatose survivors 
of out-of-hospital VF. Exclusion criteria were less than 
18 years of age, less than 50 year old women (due 
to possible pregnancy), cardiogenic shock (defined as 
systolic arterial pressure under 90mmHg after return 
of circulation) and possible causes of trauma other 
than CA itself (for instance, head injury, drug over-
dose or stroke).
Randomization divided this population into two 
groups: that of conventional treatment and that of 
induction to hypothermia. Ice packs were applied to 
those of the latter group to foster temperature de-
crease, already at the site of out-of-hospital care. Upon 
arrival at the hospital, measures for hypothermia were 
intensified. All patients were submitted to labora-
tory tests and to mechanical ventilation, in addition 
to correction of possible hemodynamic instability. 
After neurological evaluation they were sedated with 
midazolam and given vecuronium for neuromuscu-
lar blockade. Therapy with thrombolytics or heparin 
was used according to requirements. All were given 
aspirin and arterial pressure, arterial blood gases (cor-
rected for temperature), glycemia and serum potassi-
um were constantly monitored. The central reference 
temperature measurement was the tympanic until a 
Swan-Ganz catheter was introduced. Ice packs were 
removed when the central temperature reached 33º C. 
Temperature was maintained for 12 hours, with the 
patient always sedated and paralyzed. After the 18th 
hour, patients were rewarmed with a blanket with hot 
air for the next 6 hours.
A good neurological outcome (understood by the 
authors as discharge to home or rehabilitation phys-
iotherapy) was achieved by 49% of patients. Among 
patients submitted to normothermia, 26% had a good 
outcome when the same criteria are used. After ad-
justments for age and time of CA, the odds ratio for 
good outcome in the group with hypothermia, when 
compared to the group with normothermia, was rath-
er significant: 5.25 with p=0.011. There was no dif-
ference in the frequency of adverse events, although in 
the hypothermia group there was, on an average, more 
vascular systemic resistance, a lower cardiac index and 
higher glycemias. 
An important multicentric European study,(6) de-
veloped in nine centers of five European countries, 
included patients victims of VF or pulseless ventricu-
lar tachycardia (VT) with ages ranging from 18 to 75 
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years(6). Patients that had some probable non-cardiac 
cause for CA, in addition to patients who stayed more 
than 15 minutes without basic life support or patients 
who took more than 60 minutes for the return of 
spontaneous circulation were excluded. Patients who 
reached the emergency room already with a very low 
temperature (tympanic temperature less than 30º C), 
pregnancy, comatose state even before CA, responsive 
to verbal orders after return of spontaneous circula-
tion, evidence of hypotension, hypoxemia, pre-ex-
isting coagulopathy or terminal disease were also ex-
cluded from the study. The primary outcome of this 
study was neurological assessment six months after 
CA. Patients were ranked according to the Pittsburgh 
cerebral performance categories: 1 (good recovery), 2 
(moderate disability), 3 (severe disability), 4 (vegeta-
tive state) and 5 (death). 
Of the patients who received therapeutic hypo-
thermia, 55% were classified as 1 or 2 after six months 
of the event, when compared to 39% of those with 
conventional treatment, a statistically significant dif-
ference. Mortality at six months was of 41% in the 
hypothermia group, significantly lower than the 55% 
of the normothermia group. In this study, contrary to 
what might be expected, complication rates that could 
result from therapeutic hypothermia did not differ be-
tween the two groups. 
WHEN HYPOTERMIA SHOULD BE INDI-
CATED?
The ILCOR guidelines recommend that TH should 
be performed in every adult patient that remains un-
conscious after recovering from a CPR due to a out-
of-hospital VF. They must be cooled up to 32 to 34º 
C for 12 to 24 hours. This technique would be also 
beneficial for other CA rhythms and for intra-hospital 
CA.
This treatment strategy seems to be quite efficient 
and only 6 patients need to be treated to save one life, 
that is to say a number needed to treat (NNT) of 6. 
Therefore there is no reason not to use this therapy as 
a routine.
TH should not be performed on patients under 
cardiac shock, after return of spontaneous circulation 
or in patients with primary coagulopathy or pregnant 
women. Thrombolytic therapy is not a contraindica-
tion for performance of TH and it is important to 
mention this because coronary diseases are the basic 
cause of many of the CA attended.(15,16)
HOW TO COOL THE PATIENT?
There are various tested cooling techniques: ice 
packs, extracorporeal circulation, iced infusions in the 
carotid artery, cape containing quite iced solutions 
(-30ºC), nasal lavage, gastric lavage, bladder lavage, 
peritoneal lavage, pleural lavage, cooling catheters, in-
fusion of iced liquids, blanket with circulating cold 
air among others.(17-21) Ideal cooling procedures must 
quickly and practically reach the target temperature, 
without causing injuries.
One of the techniques for rapid temperature de-
crease is immersion in ice water that reduces about 
9.7°C per hour, on the average, however this strategy 
is not very practical for routine use, An even faster de-
crease may be achieved, if it is possible to keep this ice 
water circulating and in contact with the patient’s skin. 
Extracorporeal circulation is also one of the methods of 
quickly reaching the target temperature,(17) however it is 
a highly invasive and unpractical treatment.
A promising method uses an intravascular catheter 
capable of cooling blood by means of an internal cir-
cuit permitting circulation of iced liquid and constant 
temperature exchange with the blood, reducing cen-
tral temperature about 1.4°C per hour.(18) Application 
of ice packs has proven efficient, reducing on the aver-
age 0.9° C per hour of application.(19) 
 Probably, the most practical and agile method 
is intravenous infusion of iced fluid (at 4°C). Rajek et 
al.(20) administered iced saline solution (4°C) to volun-
teers at a speed of 40 mL/kg, 30 minutes by means of 
central catheter and it was possible to safely achieve a 
5°C reduction of central temperature per hour. Ber-
nard et al.(21) cooled patients who returned to spon-
taneous circulation by using Ringer lactate at 4°C in 
an infusion of 30mL/kg for 30 minutes, achieving a 
temperature decrease at an average speed of 3.2°C per 
hour, also in a safe way. Infusion of iced liquid, prob-
ably is the most promising, as it is fast, practical, safe 
and low cost.
Some topics related to cooling must still be de-
fined and future studies are required to answer them. 
Perhaps cooling measures should begin already dur-
ing cardiopulmonary resuscitation (CPR) or only af-
ter return of spontaneous circulation? At what ideal 
temperature should the patient be kept? For how 
long should patients, ideally, be maintained cooled 
to achieve maximum benefits with minimum risk? 
Which is the quickest form of cooling that is safe? At 
what speed should patients be rewarmed?
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HOW TO REWARM THEM?
The ideal temperature for maintenance of thera-
peutic hypothermia in patients who recovered sponta-
neous circulation is unknown. ILCOR recommenda-
tions follow the first two main works: from 12 to 24 
hours. Rewarming may be passive (about 0.5°C per 
hour) or active (using a thermal blanket for approxi-
mately 1°C per hour). Eventually, a slightly warmed 
saline solution infusion may be called for.(22) Maybe 
patients who are able to reach the target temperature 
more quickly and soon after CA require less time of 
hypothermia, however this hypothesis has to be con-
veniently studied.
MONITORING OF CENTRAL TEMPERATURE 
The ideal temperature measurement would be 
measuring the cerebral intraventricular temperature, 
which is unfeasible in post-CA patients. Studies have 
shown that there are no significant differences be-
tween jugular vein, subdural, tympanic membrane, 
pulmonary artery temperatures and bladder tempera-
ture. Rectal temperature is inferior for monitoring of 
central temperature. Axillary temperature cannot be 
used under any circumstances as a parameter to decide 
for cooling or warming.
The two largest studies on TH post-CA, at some 
point of monitoring, used tympanic and bladder tem-
perature.(5,6) For this reason, together with esophageal 
temperature, they are the more often used monitoring 
modalities. 
LATEST EVIDENCES
 In the scenario of intensive care medicine, a pro-
spective study by Storm C. et al.(23) assessed 52 pa-
tients, with a mean age of 62 years, submitted to 
hypothermia after return of spontaneous circulation 
post-CA; their data were compared to a historical co-
hort (n=74) treated before formal recommendation 
of use of hypothermia. The group submitted to hy-
pothermia had a significantly shorter length of stay 
in the ICU and of time on mechanical ventilation 
as well as better neurological outcome in up to one 
year.
CONCLUSION 
The evidence shows a benefit of using TH for re-
covery of post-CA patients. Most studies were car-
ried out in patient survivors of out-of-hospital VF/
VT, that is why at this rhythm of CA therapeutic 
hypothermia is definitely indicated. In patients vic-
tims of CA at other rhythms or intra-hospital CA, 
the same amount of data is not available on applica-
tion of TH. Therefore we are not able to assertively 
state the benefit of this therapy for these subgroups. 
Nevertheless, there is a theoretical rationale and a 
few short works that lead us to suppose that TH may 
be also useful at other rhythms or in victims of intra-
hospital CA. 
The units must establish a protocol of induced hy-
pothermia to optimize treatment for this profile of pa-
tients, for instance that available in chart 2.
Chart 2 – Protocol for induction of hypothermia after cardiorespiratory arrest
Protocol for induction of hypothermia after cardiorespiratory arrest 
Stock of material 
1. Saline solution at 0.9% (or other crystalloid) – bags of 1000 mL – at 4°C
2. Ice packs
3. Clean bandages 
4. Thermal mattress
5. Kit for Swan – Ganz or central venous access and invasive arterial pressure or esophageal thermometer
6. Multiparameter monitor
7. Drugs for sedation, analgesia (fentanyl, midazolam and propofol) and neuromuscular blocker (atracurium,cisatracurium or pa-
racuronium) 
8. Foley probe 
9. Evaluate topic skin protectors and eye drops for protection of the cornea.
10. Prophylaxis of venous thromboembolism 
11. Prophylaxis of acute injury of the gastric and duodenal mucosa
Continue...
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Chart 2 – Continuation
Protocol for induction of hypothermia after cardiorespiratory arrest 
Purpose of the protocol 
1. Ascertain that there are no exclusion criteria 
2. Initiate sedation, analgesia and neuromuscular blockade
3. Induction of hypothermia ice packs and crystalloid solution 30-50ml/Kg
4. Maintenance of central temperature at 32 to 34°C for 12 to 24 hours 
5. Speed of slow rewarming – Maintain sedation and neuromuscular blockade
6. Monitor potential complications 
Inclusion criteria Exclusion criteria
1. Post-CA with return of spontaneus circulation (specially pulseless 
VF or VT) 
2. More than 18 years of age. Women at fertile age must have nega-
tive pregnancy test
3. Comatose patients after return of spontaneous circulation 
 4. Mechanical ventilation 
5. Arterial systolic pressure must be kept above 90 mmHG sponta-
neously or by using volume pressors and/or vasopressors 
1. Other reason for comatose state (drug overdose, brain in-
jury, stroke, status epilepticus) 
2. Pregnancy
3. Initial temperature < 32oC 
4. Coagulopathies or previous bleeding
Sedation and paralysis 
1. Fentanyl – attack dose – 1 to 2 mcg/kg + maintenance dose – 1 to 4 mcg/kg/hour 
2. Midazolam – attack dose – 2 to 6 mg + maintenance dose – 1 to 2mg/hour
3. Propofol – begin with 5 mcg/kg/min 
4. Pancuronium – 1 ampoule - 4mg followed by 0.1 to 0.2 mg/kg every 1 to 2 hours
Start cooling Start rewarming 
Interventions during cooling – Interpret ECG and determine need 
to perform cineangiocoronography or thrombolysis. Check battery 
of laboratory tests.
1. Infuse 30 to 50 ml/kg of SS 0.9% or RL at 4°C for 30 minutes to 
induce hypothermia 
2. Keep patient naked, under mechanical ventilation, with damp 
compresses 
3. Keep ice on the regions of skin folds such as neck, inguinal re-
gions, axillae, lower limbs, trunk and abdominal region.
4. Monitor MAP, CVP and central temperature. 
5. Monitoring of temperature may be by esophageal, tympanic tem-
perature or by Swan-Ganz catheter. 
6. Target temperature between 32 and 34°C – if needed repeat in-
fusion of crystalloid at 4°C, if the patients did not reach 34º C in 
4 hours
1. Start rewarming programmed 18 hours after induction of 
hypothermia. Speed of rewarming must be of 0.5°C/hour
2. Attention to need of fluids during rewarming
3. Assess interruption of potassium replacement when appro-
priate
4. Maintain sedation and neuromuscular blockade until pa-
tient reaches 36ºC
Monitoring potential complications
1. Arrhythmias 
2. Infections
3. Coagulopathies 
4. Status epilepticus 
5. Reboound hypothermia 
CA – cardiac arrest; VF – ventricular fibrillation; VT – ventricular tachycardia; S – stroke; ECG – electrocardiogram; SS – saline solution; 
RL – ringer lactate; MAP – mean arterial pressure; CVP – central venous pressure. 
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RESUMO 
Os sobreviventes de parada cardiorrespiratória freqüentemen-
te apresentam lesão cerebral isquêmica associada a piores desfe-
chos neurológicos e óbito. A hipotermia terapêutica melhora os 
desfechos entre os sobreviventes comatosos após manobras de 
reanimação. Considerando sua recomendação formal para em-
prego terapêutico pós-recuperação da circulação espontânea na 
parada cardiorrespiratória, o objetivo deste estudo foi rever os 
principais aspectos clínicos relativos à hipotermia terapêutica. Foi 
feita revisão através de pesquisa não-sistemática de artigos atra-
vés das palavras-chave “parada cardiorrespiratória, resfriamento, 
hipotermia, síndrome pós-reanimação” na base de dados MedLi-
ne. Adicionalmente, referências destes artigos foram igualmente 
avaliadas. Pacientes adultos inconscientes com circulação espon-
tânea após parada cardiorrespiratória extra-hospitalar devem ser 
resfriados quando o ritmo inicial for fibrilação ventricular ou ta-
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